Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin, Vitamin E, and N-Acetyl Cysteine in NASH
NCT06105060Phase 1Completed
- Sponsor
- Beni Suef University
- Start
- Dec 2023
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial of rosuvastatin and acetylcysteine in Nonalcoholic steatohepatitis (NASH), sponsored by Beni Suef University. Primary endpoints: Blood pressure at 6 months, Height at 6 months and 14 more. Started Dec 2023; status: completed.
02
Drugs
rosuvastatinacetylcysteine
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT06105060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06105060.